Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-28 @ 5:52 AM
Study NCT ID:
NCT06612268
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2024-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sponsor:
Novo Nordisk A/S
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Sickle Cell Disease | View |
Keywords: